Precision financing for Durable/curative Therapies

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Cell and gene therapies are transforming patients’ lives and payment models. This panel explores how downstream innovation is matching upstream scientific innovation to enable patient access. Hear how the NEWDIGS FoCUS consortium is tailoring performance-based annuities, subscription / “Netflix” models and other approaches to address the durability, payment timing and actuarial financial challenges of these new therapies.
Moderator
photo
CEO
Anthos Therapeutics Inc
Speakers
photo
Senior Director, Access Value and Evidence Strategy
bluebird bio
photo
Senior Advisor
MIT FoCUS Project
photo
Strategic Director
MIT NEWDIGS